SEC Form 4 · accession 0001140361-17-037277
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher G Roberts
Director
Period of report
Sep 29, 2017
Accepted (ET)
Oct 3, 2017 · 12:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Sep 29, 2017 | M | 25,934 | $38.98 | A | 224,337 | D | |
| ResMed Common Stock | holding | — | — | — | 298,900 | I | Cabbit Pty Ltd | |
| ResMed Common Stock | holding | — | — | — | 136,000 | I | AceMed Pty Ltd | |
| ResMed Common Stock | holding | — | — | — | 23,200 | I | Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $38.98 | Sep 29, 2017 | M | 25,934 | D | Nov 11, 2013 | Nov 15, 2019 | ResMed Common Stock | 25,934 | 0 | D |
Explanation of responses
- F1Transaction to exercise options and hold shares acquired through purchase.
- F2Options vest in full on (i) the first November 11 following the grant date, or (ii) the first annual shareholder's meeting following grant date.